Objective: This study aims to assess the agreement between the menopausal transition stages defined by annual interviews or annual follicle-stimulating hormone levels and the menopausal transition stages defined by monthly menstrual calendars, as well as factors associated with discordance.
T he stages of a woman's reproductive life have become more clearly defined in the past decade. The 2001 Stages of Reproductive Aging Workshop (STRAW) defined the menopausal transition (MT) as having two distinct perimenopause stages: early and late. The start of early MT is characterized by increased variability in menstrual cycle length, defined as a change in consecutive cycle lengths of at least 7 days, whereas the start of late MT is characterized by amenorrhea of at least 60 days. 1 These definitions have since been validated by ReSTAGE Collaboration 2<4 and are included in the current STRAW +10 recommendations. 5<8 STRAW also noted that serum follicle-stimulating hormone (FSH) levels increase during the MT, and studies have demonstrated that mean FSH levels differ between the different stages of the MT 9 and that the rates of FSH level changes also differ. 10, 11 The data used to validate menstrual bleeding markers for the early MT and late MT stages came from prospectively collected menstrual calendars, the preferred method of data collection. 12 However, data collection using menstrual calendars is more labor-intensive and therefore more costly than studies that use questionnaires. Several cohort studies of midlife women have used annual interviews to classify women's menopause status, yet few studies have assessed the agreement between information obtained from annual interviews and information obtained from menstrual calendars among midlife women. The Melbourne Women's Midlife Health Project found that the interview questions used in their study had low sensitivity for picking up menstrual cycle variability and menses flow variability. 13 The Seattle Midlife Women's Health Study (SMWHS) compared interview questions inquiring about menstrual cycle irregularity to menstrual calendars and reported a weak agreement. 14 Neither of these two studies examined factors that influence agreement. The purpose of this article was to assess the agreement between MT stages defined by annual interviews or annual FSH levels and MT stages defined by monthly menstrual calendars in the Study of Women's Health Across the Nation (SWAN) and to examine demographic and lifestyle factors that may influence this agreement.
METHODS
SWAN is a multiethnic, multisite, cohort study of middleaged women. The design of the study has been previously described. 15 Briefly, a cross-sectional screening survey was administered to 16,065 women at seven sites between 1995 and 1997 to assess eligibility for enrollment into the cohort study. Each site recruited white women and women from one specified minority group (African-American women in Pittsburgh, Boston, southeastern Michigan, and Chicago; Japanese women in Los Angeles; Chinese women in Oakland; and Hispanic women in Newark). Eligibility criteria for the cohort study included the following: aged 42 to 52 years; with an intact uterus; with at least one menstrual period and had not used reproductive hormones in the previous 3 months; self-designation as a member of the targeted racial/ethnic group and residence in a geographic area of one of the seven clinic sites; ability to speak English, Cantonese, Japanese, or Spanish; and ability to give verbal consent. A total of 3,302 women were enrolled in the cohort study at the seven sites. This analysis includes data from 1,950 women who were enrolled at four study sites (Boston, southern Michigan, Oakland, and Los Angeles) for which cleaned menstrual calendar data were available. The institutional review board at each study site approved the protocol.
Annual study visits began in 1996, and follow-up visits have been conducted since that time. This article includes data through follow-up visit 10. Each visit consisted of intervieweradministered and self-administered questionnaires that included questions on menstrual characteristics, sociodemographic experiences, lifestyle, and medical history. The participants also underwent physical assessments, including a blood draw.
A self-administered monthly menstrual calendar component began in 1996 and continued through 2006. Participants filled out the menstrual calendars daily to capture days when any spotting or bleeding occurred. On the last day of the month, women indicated whether no bleeding occurred in that month and answered questions about hormone use and gynecological procedures that could affect bleeding. Women were asked to continue filling out and returning the monthly calendar for 2 years after their last menstrual bleed.
Women's menstrual experience was assessed by examining their sequence of menstrual cycle lengths. A menstrual cycle consists of a bleeding episode and a subsequent bleed-free interval of at least 3 days. Menstrual cycle length was calculated using the definitions originally developed by the World Health Organization 12 and previously used in ReSTAGE analyses. 2, 4 A serum sample was obtained at each annual interview, in the morning after an overnight fast on days 2 to 5 (days 2-7 from January 1996 through May 1996) of a spontaneous menstrual cycle. Two attempts were made to obtain a sample on days 2 to 5. If a timed sample could not be obtained, a random fasting sample was taken within 90 days of the anniversary of the baseline visit. FSH assays were conducted using an ACS-180 automated analyzer (Bayer Diagnostics Corp., Norwood, MA). FSH concentrations were measured with a two-site chemiluminometric immunoassay. The interassay coefficient of variation was 12.0%, the intraassay coefficient of variation was 6.0%, and the lower limit of detection was 1.1 IU/L.
Classification of reproductive stage Menstrual calendar
Bleeding criteria for the onset of early and late MT stages were defined from the calendar data, using definitions developed by STRAW/ReSTAGE. 1<4 We defined the bleeding marker of early MT as a persistent difference of 7 days or greater in the menstrual cycle length of consecutive cycles. Persistence was defined as recurrence within 10 cycles of the first variable-length cycle. The start date of early MT was defined as the first day of the first variable-length cycle. We defined two bleeding markers for late MT: (1) the first day of the first occurrence of a cycle length of 90 days or greater, consistent with the SWAN annual interview algorithm; and (2) the first occurrence of a cycle length of 60 days or greater, consistent with the STRAW/ReSTAGE definition. The final menstrual period (FMP) was defined as the first day of a bleeding segment that was followed by at least 12 months of amenorrhea. For women who had missing calendars during the 12 months of amenorrhea, we accepted the FMP in the menstrual calendar if the date was less than 31 days different from the FMP date identified in the annual interview or if there were only two missing calendars during the 12 months of amenorrhea.
Annual interview
The annual interview ascertained information on menstrual bleeding since the last study visit, which was used to define a woman's menopause status. The questions, based on the Massachusetts Women's Health Study, 16 included the following four questions: BDid you have any menstrual bleeding since your last study visit? Did you have any menstrual bleeding in the last 3 months? What was the date that you started your most recent menstrual bleeding? Which of the following best describes your menstrual periods since your last study visit: they have become farther apart, become closer together, occurred at more variable intervals, stayed the same, become more regular, or do not know?[ Early MT stage was defined as the first visit where a woman who had had a menstrual period within the last 3 months reported that the variability in her menstrual periods had increased (have become farther apart, become closer together, or occurred at more variable intervals). Late MT stage was defined as the first visit where a woman reported that she had a menstrual period in the last year but had not had a menstrual period in the last 3 months at the time of the interview. FMP was defined retrospectively as the self-reported date of the last menstrual period after at least 12 months of amenorrhea not due to pregnancy or lactation.
Follicle-stimulating hormone
Based on previous analyses of FSH trajectories using the SWAN population, 10 we defined early MT by FSH level as the first annual visit with a serum FSH concentration between 15 and 29.9 IU/L. We defined late MT by FSH level as the first annual visit with a serum FSH concentration of 30.0 IU/L or greater.
Baseline covariates
Ethnicity was self-defined and categorized as African American, Chinese, Japanese, or white. Highest education (high school graduate/GED or less than high school vs at least some college) and marital status (single, married, separated, widowed, or divorced) were assessed at baseline. Economic strain was assessed during the initial screening survey with the question BHow hard is it to pay for basics?[ and was categorized as very hard, somewhat hard, or not hard. Prior use of female hormone therapy (not oral contraceptives) was also assessed during the initial screening survey.
Height was measured without shoes using either a metric folding wooden ruler or a measuring tape (home and some clinic visits) or a fixed stadiometer (clinic visits). Weight was measured without shoes and in light indoor clothing using a portable digital scale (home and some clinic visits) or either a digital scale or a balance beam scale in the clinic. Body mass index (BMI), calculated as weight in kilograms divided by height in meters squared, was categorized as underweight (G18.5 kg/m 2 ), normal weight (18.5-24.9 kg/m 2 ), overweight (25.0-29.9 kg/m 2 ), or obese (Q30.0 kg/m 2 ).
Statistical analyses
Data were analyzed using SAS version 9.2 (SAS Institute Inc., Cary, NC). To compare the baseline characteristics of eligible women and other participants, we used Pearson's W 2 test or Fisher's exact test to compare proportions, and Student's t test to compare means. Analyses were restricted to women who had at least 10 consecutive menstrual cycles recorded in the menstrual calendar and who never started hormone therapy during the study. Because failure to observe transition stages was common among women not observed through the FMP and because the analyses were consistent (data not shown), we present results only for analyses among women with documented FMP (n = 379). Women who were already in early MT at baseline interview (ie, they reported increased variability in menstrual periods in the last year) were excluded from the assessment of early MT because it was not possible to assess the time of onset of early MT in these women. Similarly, women who had serum FSH concentrations of 15.0 IU/L or greater at baseline were excluded from the assessment of early MT in comparison with FSH, and women who had serum FSH concentrations of 30.0 IU/L or greater at baseline were excluded from comparisons of both early and late MT in analyses comparing MT stage defined by FSH versus MT stage defined by menstrual calendar.
To examine the agreement between MT stage by annual interview and MT stage by menstrual calendar, we determined the date of entry into each MT stage in the calendar and compared it with the MT stage at the next annual interview. If the annual interview MT stage indicated a change in stage from the prior visit, the annual interview MT stage and the calendar MT stage were determined to have occurred at the same time. If the annual interview MT stage changed at an earlier visit, the annual interview MT stage was determined to have occurred before the menstrual calendar MT stage. If the annual interview MT stage changed at a later visit, it was determined to have occurred after the menstrual calendar MT stage. If the annual interview MT stage, the menstrual calendar MT stage, or both were not observed, this was also characterized. Percentages in each of these agreement categories were calculated. An example is shown in Figure 1 . In this example, the early MT bleeding marker was observed in the menstrual calendar between annual visit 2 and visit 3. If the annual interview on visit 3 observed a change in MT stage from pre-MT stage to early MT stage, the two methods occurred at the same time (0). If the annual interview observed a change on visit 4, early MT stage by menstrual calendar is defined as having occurred one visit before the annual interview (j1). If the annual interview observed the change on visit 2, early MT stage by menstrual calendar is defined as having occurred one visit after the annual interview (+1).
FIG. 1. Example of the comparison between annual interviews (baseline and visits) and menstrual calendars. Early menopausal transition (MT)
bleeding marker occurs in the menstrual calendar between annual visits 2 and 3. If the annual interview notes a change in menopause status from premenopausal to early perimenopausal on visit 3, the two methods are in agreement (0). Instead, if the annual interview notes a change in menopause status on visit 4, early MT stage by menstrual calendar occurs one visit before the annual interview (j1). If the annual interview notes a change in menopause status on visit 2, early MT stage by menstrual calendar occurs one visit after the annual interview (+1).
Two definitions of agreement were used for each comparison. Strict agreement was considered concordant when the menstrual calendar MT stage and the annual interview MT stage occurred at the same time, or when both the calendar MT stage and the annual interview MT stage were not observed. Discordance was noted when the timing of the annual interview MT stage and the timing of the menstrual calendar MT stage did not match, or when either the annual interview MT stage or the menstrual calendar MT stage was not observed. A similar definition of strict agreement was used when comparing the calendar to the annual FSH level.
When comparing the menstrual calendar to the annual interview, relaxed agreement was defined as the menstrual calendar MT stage and the annual interview MT stage occurring at the same time, the menstrual calendar MT stage occurring one visit before the annual interview (j1), or both the menstrual calendar MT stage and the annual interview MT stage not being observed. Relaxed agreement for the menstrual calendar versus the annual FSH was defined as the menstrual calendar MT stage and the annual FSH MT stage occurring at the same time, the menstrual calendar MT stage occurring one visit before the annual FSH (j1), the menstrual calendar occurring one visit after the annual FSH (+1), or both the menstrual calendar MT stage and the annual FSH MT stage not being observed.
Cohen's J statistics were calculated for 2 Â 2 tables for both strict agreement ( Fig. 2 ) and relaxed agreement. J values can range from j1 to 1, with negative values indicating agreement less than chance, zero indicating chance agreement, and positive values indicating agreement greater than chance. 17 To interpet our J values, we used cutoffs that are similar to the often cited Landis and Koch 18 article: G0.00, poor agreement; 0.01 to 0.20, slight (poor) agreement; 0.21 to 0.40, fair agreement; 0.41 to 0.60, moderate agreement; 0.61 to 0.80, substantial agreement; 0.81 to 1.00, almost perfect agreement. Logistic regression was used to examine baseline factors that influenced discordance for both strict agreement and relaxed agreement.
RESULTS
Among the 1,950 SWAN participants from the four study sites, 1,852 (95.0%) enrolled in the calendar study. Participation rates were as follows: Boston, 94.0%; southeastern Michigan, 90.8%; Oakland, 98.0%; Los Angeles, 97.6%. Of these women, 1,339 (72.3%) recorded at least 10 consecutive untreated nonmissing cycles and were eligible for this analysis. Of the 1,339 eligible women, 379 (28.3%) had their FMP recorded in the calendar study, 23 (1.7%) had a hysterectomy, 381 (28.5%) started taking female hormones, 435 (32.5%) did not complete the calendar study through FMP or hysterectomy, and 121 (9.0%) were still recording menstrual bleeding at the end of the calendar study. Women who had their FMP recorded were older at study enrollment and were more likely to be from the Oakland and Los Angeles study sites (thus Chinese or Japanese) than other eligible women. Education, marital status, economic strain, BMI, and history of female hormone use did not differ at baseline between women whose FMP was recorded and women whose FMP was not recorded ( Table 1) .
Comparison of MT stage by menstrual calendar versus MT stage by annual interview
For 42.8% of women, early MT stage by menstrual calendar occurred at the same time as early MT stage by annual interview (Table 2) . However, a large percentage of women (29.2%) had their early MT stage by menstrual calendar before the onset of early MT stage by annual interview. A smaller percentage (11.2%) had onset of early MT stage reported in the annual interview before the occurrence of early MT stage by annual interview. An early MT stage by annual interview, an early MT stage by menstrual calendar, or both were not observed in 16.8% of women. A poor agreement was found between early MT stage by menstrual calendar and early MT stage by annual interview for both the strict definition (J = j0.13; 95% CI, j0.25 to j0.02) and the relaxed definition (J = 0.01; 95% CI, j0.12 to 0.13).
Women from the Boston study site were more likely to be discordant (odds ratio [OR], 2.17; 95% CI, 1.03 to 4.53) than women from Los Angeles when using the strict agreement definition. This association did not persist when using the relaxed definition. Race/ethnicity, education, age, marital status, economic strain, BMI, and history of female hormone use before the study were not associated with discordance for either agreement definition.
To compare similar definitions of late MT stage, we compared late MT stage by menstrual calendar (defined as the first cycle length of at least 90 d) with late MT stage by annual interview ( Table 2 ). The two classifications were the same in 13.5% of women. Late MT stage by menstrual calendar occurred earlier than late MT stage by annual interview in 41.2% of women. Only 1.9% of late MT stage by menstrual calendar occurred after late MT stage by annual interview. A large percentage of women (21.4%) did not have late MT stage by annual interview but had late MT stage by calendar, whereas 12.1% of women did not have late MT stage identified by either method. A poor agreement was found between late MT stage by menstrual calendar and late MT stage by annual interview for both the strict definition (J = j0.18; 95% CI, j0.26 to j0.11) and the relaxed definition (J = j0.05; 95% CI, j0.04 to 0.14).
We next examined the agreement between the STRAW/ ReSTAGE preferred definition for late MT stage by menstrual calendar (cycle length of at least 60 d) and late MT stage by annual interview. The two classifications were the same in 6.1% of the women. Similar to the analysis of the 90-day definition, late MT stage by menstrual calendar occurred before late MT stage by annual interview in most women (56.2%). Late MT stage by menstrual calendar occurred after late MT stage by annual interview in a very small number of women (0.6%). The percentage of women who did not have late MT stage by annual interview but had late MT stage by menstrual calendar was 26.6%, whereas 3.7% had late MT stage by annual interview but not late MT stage by calendar. A small number of women (6.9%) did not have late MT stage identified by either classification method. Similar to the results for the 90-day definition, a poor agreement between late MT stage by menstrual calendar and late MT stage by annual interview was found for the 60-day definition for strict agreement (J = j0.08; 95% CI, j0.12 to j0.03) and relaxed agreement (J = j0.02; 95% CI, j0.07 to 0.03).
We examined factors that influence discordance, using the strict agreement definition, in the classification between late MT stage by menstrual calendar and late MT stage by annual interview for the 90-day definition and the 60-day definition. Women from Oakland were more likely to be discordant than women from Los Angeles in both the 90-day definition (OR, 2.15; 95% CI, 1.18 to 3.93) and the 60-day definition (OR, 2.33; 95% CI, 1.04 to 5.26). In both the 90-day analysis and the 60-day analysis, Chinese women were more likely to be discordant than white women (90-d late MT definition: OR, 2.09; 95% CI, 1.04 to 4.23; 60-d late MT definition: OR, 2.71; 95% CI, 1.00 to 7.36). African-American women were more likely to be discordant than white women for the 90-day definition (OR, 2.39; 95% CI, 1.00 to 5.71), but not for the 60-day definition (OR, 1.70; 95% CI, 0.62 to 4.69). Women with high school education or less were more likely to be discordant in both analyses (90-d late MT stage: OR, 2.16; 95% CI, 1.08 to 4.30; 60-d late MT stage: OR, 2.92; 95% CI, 1.02 to 8.40). When examining factors that influence discordance using the relaxed agreement definition, all of the above associations disappeared, except for one: women from Oakland were more likely to be discordant than women from Los Angeles for the 60-day definition (OR, 1.88; 95% CI, 1.02 to 3.45). Age, marital status, economic strain, BMI, and history of female hormone use before the study were not associated with discordance in the analyses for the 90-day definition or the 60-day definition for either strict agreement or relaxed agreement.
Comparison of MT stage by menstrual calendar versus MT stage by FSH
A comparison of early MT stage by menstrual calendar versus early MT stage by FSH level at the annual visit is shown in Table 3 . For 20.8% of the women, the classification of early MT stage by FSH level occurred at the same time as the classification of early MT stage by menstrual calendar. In a similar percentage of women (16.1%), early MT stage by menstrual calendar occurred either before or after (15.4%) the classification of early MT stage by FSH level. A large percentage of women (32.2%) had an early MT stage observed in the menstrual calendar but no early MT stage by FSH level, while 10.1% of women had early MT stage by FSH level but no early MT stage by menstrual calendar. A small percentage of women (5.4%) did not have their early MT stage classified For comparison of early MT stage by menstrual calendar versus early MT stage by annual interview, women who were determined to be in the early MT stage by baseline interview were excluded. If the early MT stage by menstrual calendar occurred at the same time as or after the late MT stage by menstrual calendar, the early MT stage by menstrual calendar was set to missing.
by either method. A poor agreement was found between early MT stage by menstrual calendar and early MT stage by FSH level for both strict agreement (J = j0.44; 95% CI, j0.57 to j0.30) and relaxed agreement (J = j0.20; 95% CI, j0.33 to j0.07). None of the factors examined (study site, race/ ethnicity, age, education, marital status, economic strain, BMI, and history of female hormone use before the study) were associated with discordance by either the strict agreement definition or the relaxed agreement definition.
When we compared the onset of late MT by menstrual calendar (90-d definition) to the onset of late MT stage by FSH level (Table 3) , we observed that many (43.1%) women were classified as late MT stage by menstrual calendar after being classified as late MT stage by FSH level. Only 12.7% of women were classified as late MT stage by menstrual calendar before being classified as late MT stage by FSH level. A small percentage of women were classified as late MT stage by menstrual calendar but not by FSH level (3.3%) or did not have either marker observed (2.0%). However, 20.3% of women had a late MT stage by FSH level but not a late MT stage by annual interview. A poor agreement was found between late MT stage (90-d definition) by menstrual calendar and late MT stage by FSH level for both strict agreement (J = j0.32; 95% CI, j0.42 to j0.23) and relaxed agreement (J = j0.12; 95% CI, j0.19 to j0.05). Based on the strict agreement definition, obese women were less likely to be discordant than women with normal BMI (OR, 0.39; 95% CI, 0.20 to 0.77). This association became nonsignificant when the relaxed agreement definition was used (OR, 0.57; 95% CI, 0.32 to 1.03). Older women were less likely to be discordant when using the relaxed agreement. For every 1-year increase in baseline age, the OR (95% CI) equalled 0.91 (0.83 to 0.99). This association did not hold for the strict agreement definition. Study site, race/ethnicity, education, marital status, economic strain, and history of female hormone use before the study were not associated with discordance with either agreement definition.
When we compared late MT stage by menstrual calendar (60-d definition) to late MT stage by FSH level ( Unlike the comparison for the 90-day definition, BMI was not associated with discordance with either definition. Similar to the 90-day definition, older women were less likely to be discordant when using the relaxed definition. For every 1-year increase in baseline age, the OR (95% CI) equalled 0.88 (0.81 to 0.97). Study site, race/ethnicity, education, marital status, economic strain, and history of female hormone use before the study were not associated with discordance with either agreement definition.
DISCUSSION
This study assessed the agreement between MT stage defined by menstrual calendars compared with MT stage defined by annual interviews and annual FSH levels in SWAN. A poor agreement was found between menstrual calendars and annual interviews, using both a strict definition of agreement and a relaxed definition of agreement. The menstrual calendars identified the start of early MT and late MT earlier than the annual interviews. For early MT, 29.2% of women had had their status change in the menstrual calendar before it was reported in the annual interview. Late MT stage by the 90-day menstrual calendar occurred earlier in 41.2% of the women, and late MT stage by the 60-day menstrual calendar occurred earlier in 56.2% of women. When using the strict agreement definition, a poor agreement was also found between the menstrual calendars and the annual FSH levels using both strict and relaxed agreement definitions.
Increasing variability in menstrual cycle frequency has been a hallmark description of the onset of the MT. 4, 19 Using this definition to mark the start of early MT, we found a poor agreement between menstrual calendars and annual interviews, as the annual interviews frequently identified early MT 1 to 3 years later than the menstrual calendars. Other studies of midlife women have found a poor agreement between menstrual calendars and interviews when defining menstrual cycle variability. The Melbourne Women's Midlife Health Project reported that annual interviews had low sensitivity to detecting menstrual cycle irregularity, defined as change in menstrual cycle frequency. 13 The SMWHS reported a poor agreement between annual interviews and menstrual calendars in detecting menstrual cycle irregularity (Cohen's J = 0.19). 14 The reasons for a poor agreement for early MT may be attributed to differences in women's versus researchers' interpretations of menstrual cycle variability. The annual interview question used to define the start of early MT in SWAN asked a woman to decide if her menstrual periods were farther apart, closer together, or more variable since her last visit. No definition of Bfarther apart,[ Bcloser together,[ or Bmore variable[ was provided. Therefore, women might not use the same definition, or women might not use the same definition as the researchers. They might only note increased cycle variability when the difference in cycle length is greater than 7 days or when differences start to occur more frequently. Our data suggest that this may be true given that, for approximately one third of the women, the menstrual calendars identified the start of early MT stage earlier than the annual interviews.
In this study, we also found a poor agreement between menstrual calendars and annual interviews regarding the onset of late MT stage. We used two definitions for the start of late MT in menstrual calendars: a cycle length of at least 90 days and a cycle length of at least 60 days. The 90-day definition gained prominence in the 1990s 20 and was easily applied in the clinical setting. Recently, the 60-day definition has been found to be a better marker for late MT stage because 9.0% to 21.4% of women have passed their FMP before experiencing 90 days of amenorrhea. 2 In this analysis, women were more likely to have experienced late MT bleeding marker of at least 60 days (89.4%) than late MT bleeding marker of at least 90 days (77.8%).
As with early MT, the menstrual calendars place the start of late MT earlier than the annual interviews. This finding is not surprising given the structure of the annual interview questions used to identify late MT. The questions were based on the SMWHS, 21 which was designed to capture women who were currently experiencing 3 to 11 months of amenorrhea and were thus likely to be classified as postmenopausal at their subsequent visit. 20 The annual interview failed to detect late MT stage in 33.5% of the women. All of these women were classified as having changed from early MT directly to being postmenopausal. The annual interview questions ascertained only whether a woman currently has not bled for 3 months, not whether she had experienced an episode of amenorrhea lasting 90 days or longer in the past year. If in the past year a woman had had a menstrual cycle that was 90 days or greater but also had a menstrual cycle in the 3 months preceding the annual interview, she would be classified as being in early MT by annual interview. However, she would be staged as late MT by menstrual calendar. A better interview approach to identifying the start of late MT would be to ask about the occurrence of any cycle that was 60 days or greater since the last study visit. A similar approach was used in the SMWHS, which asked questions about skipped periods and found a good agreement (Cohen's J = 0.71) between their interview and their menstrual calendar status classification, especially once a definition of skipped period was given to study participants. 14 We found that the strict agreement for staging late MT was influenced by study site, ethnicity, and educational attainment. Chinese women were most likely to have discordant menstrual calendars and annual interviews. One US study found that Asian women were less likely to accurately recall their last menstrual cycle length; however, the association disappeared once other factors were taken into account, including education and income. 22 Our study found that women with high school education or less were more likely to be discordant. Two studies have found that women with lower educational attainment were less likely to recall their last menstrual cycle length; however, the associations were not statistically significant. 22, 23 Both of these studies also reported that women with lower incomes were less likely to accurately recall their last menstrual cycle. When using the relaxed definition of agreement, most of the associations that we observed disappeared. This suggests that, for some women, it may take longer to perceive a change in menstrual function.
This study also found a poor agreement between menstrual calendars and MT classification by annual FSH levels. Although definitive FSH staging criteria have not been established, 5<8 recent publications have given guidance on appropriate values in the SWAN population. 10 However, for early MT, one third of the women did not have an early MT identified by annual FSH levels, suggesting that single annual measurements of FSH levels frequently miss the rise of FSH. Given that FSH is characterized by high variability in this stage, 5<8 more frequent measurements may be necessary. For a late MT stage of 90 days using the strict agreement definition, we found that obese women were less likely to be discordant, consistent with evidence that obesity affects FSH levels. 10 We also found that for late MT stage (both 90-d and 60-d definitions), using the relaxed agreement definition, older women were less likely to be discordant. This is not surprising because older age is associated with higher FSH levels independent of the MT stage. 24 This study has some limitations. Because women were enrolled in the study between the ages of 42 and 52 years, left censoring probably occurred such that women may have started the MT before entry into the study. It is possible that the women determined to be premenopausal at baseline interview were already in early MT at the time that the study began. Selection bias could also have been a factor. Women who were eligible for this analysis were more likely to be younger, Chinese or Japanese, and married as compared with other SWAN participants. Eligible participants were also less likely to be overweight or obese and were less likely to experience economic strain, which could reduce power to detect associations.
CONCLUSIONS
There is poor agreement between menstrual calendars and annual interviews that use the SWAN framework in staging women during the MT. Accurately identifying the MT stage in a timely manner has implications for interventions and health care. Bone loss 25 and adverse changes in lipid profiles 26 accelerate in the last couple of years before the FMP. Treatment and lifestyle intervention should optimally begin before this period. Because menstrual calendars are considered the gold standard in measuring menstrual cycle characteristics, these results suggest the need to improve questionnaire-based approaches to classifying MT stage. Currently available instruments do not adequately capture the start of early MT. For late MT stage, questions similar to the skipped-period questions used in the SMWHS 27 are suggested. Given our findings that perception of change in menstrual function differs by ethnicity and educational attainment, questions need to be validated in a multiethnic population with varying educational backgrounds. Increasing the frequency of interviews and blood draws may also be warranted. These results also suggest that misclassification of stage may be an important concern in studies assessing changes in health status by MT stage based on annual interview classification. Reanalysis of major findings using menstrual calendarYbased classifications is probably warranted.
